Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Boston Scientific completes patient enrollment for Iliac stent trial

Boston Scientific has completed patient enrolment for the Iliac clinical trial, designed to evaluate its EPIC Self-Expanding Nitinol Stent System for the treatment of iliac artery disease.

Boston Scientific‘s trial, which will enroll 128 patients across 28 sites in the US, will assess rates of device- and/or procedure-related major adverse events and patency rates at nine months.

The EPIC Stent is designed to sustain vessel patency, while providing improved visibility and accuracy during placement.

The stent uses a Radial Tandem Architecture, which is designed to provide stent flexibility while maintaining predictable radial force characteristics throughout the entire stent size matrix.